pyridoxamine has been researched along with Fatty Liver in 1 studies
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaens, KH | 1 |
| Niessen, PM | 1 |
| Rensen, SS | 1 |
| Buurman, WA | 1 |
| Greve, JW | 1 |
| Driessen, A | 1 |
| Wolfs, MG | 1 |
| Hofker, MH | 1 |
| Bloemen, JG | 1 |
| Dejong, CH | 1 |
| Stehouwer, CD | 1 |
| Schalkwijk, CG | 1 |
1 other study available for pyridoxamine and Fatty Liver
| Article | Year |
|---|---|
Endogenous formation of Nε-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis.
Topics: Aged; Biomarkers; Biopsy; Cytokines; Enzyme Inhibitors; Fatty Liver; Female; Gene Expression; Guanid | 2012 |